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A 31P NMR study has been carried out on Friend erythroleukemia cells (FLC) induced to undergo erythroid 
differentiation in vitro. Significant levels of glycerophosphorylcholine (GroPCho) and phosphorylcholine 
(P-Cho) were identified both in the untreated cells and in their PCA extracts. In FLC treated 4 days in 
vitro with either ~ethyls~fo~de (DMSO) or he~me~ylenebi~~~de (HMBA), the in~a~lluIar con- 
centration of P-Cho was markedly increased, whereas that of GroPCho appeared to be significantly re- 
duced. HMBA was more effective than DMSO in producing this effect. The concomitant modulations of 
GroPCho and P-Cho in differentiated FLC suggest he hypothesis that erythroid differentiation involves 
modifications of the regulatory mechanisms controlling biosynthesis and catabolism of phospholipids. 
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1. INTRODUCTION 
Friend erythroleukemia cells [ 11 have been wide- 
ly used as a model system for the study of ery- 
throid differentiation [2]. FLC grown in vitro 
show little evidence of erythroid maturation 
beyond the erythroblastic stage, but markedly dif- 
ferentiate towards normoblasts when treated with 
a variety of agents [3], among which DMSG and 
HMBA are particularly active [4]. Although the 
appearance of the several erythroid markers during 
in vitro differentiation has been investigated in 
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great detail, only a few studies were carried out on 
the metabolic changes which characterize differen- 
tiated cells. NMR spectroscopy can provide signifi- 
cant, detailed information on intracellular meta- 
bolites and their interconversions, under non- 
disruptive and non-invasive conditions [5-71. “P 
NMR spectra were reported for several mam- 
malian cell lines, includi~ FLC, in [8]. Among the 
various metabolites identified in these spectra, 
GroPCho and GroPEtn deserved particular atten- 
tion. The presence of GroPCho, first detected in 
some muscles by authors in [9] was subsequently 
also identified in a variety of cell systems [9-l 1 J. 
Although the biochemical bases of the modula- 
tions of GroPCho and analogous phosphodiesters 
have not been clarified, it has been suggested that 
they may play a role as ‘markers’ of pathological 
conditions, including dystrophies or malignancy 
[g-12]. Another potential “P NMR ‘marker’ has 
been suggested to be P-Cho, a compound generally 
present in high levels in tumor lines lacking GroP- 
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Cho [ 121. An increase of P-Cho in FLC during dif- 
ferentiation has been detected recently by ‘H NMR 
methods [13]. 
We aimed at studying levels and modulations of 
both GroPCho and P-Cho in FLC, either un- 
treated or induced to differentiate with DMSO or 
HMBA, 
2. MATERIALS AND METHODS 
2.1. Cells 
Friend erythroleukemia cells were grown in 
RPM1 medium supplemented with 10% foetal calf 
serum (GIBCO). The cells were routinely seeded at 
l@/ml, twice a week. Clone 745A was obtained 
from C. Friend (New York) and clone 745-E7 was 
derived by cloning 74549 cells serially passaged i.p. 
in DBAl2 mice f 141. The culture medium used for 
inducing erythroid differentiation was adjusted to 
1.5% DMSO (v/v) or to 5 mM HMBA before the 
cells were added. Cells were seeded at 5 x lO“/ml 
and grown in roller bottles (Falcon) without any 
further medium change. Control and DMSO- or 
HMBA-treated cultures reached cell densities of 
2,0-2.3 x @/ml on day 4, and had viability (as 
judged by trypan blue dye-exclusion test) greater 
than 95%. The percentage of differentiated FLC 
was determined by benzidine staining, according to 
1151. 
2.2. Chemicals 
All reagents were of analytical grade. DMSO 
was purchased from Merck and HMBA was kindly 
prepared by Dr C. Delfini.(Rome). Extracts were 
prepared by addition of 5 ml of Hz0 and 0.5 ml of 
3O(rlo perchloric acid at O°C followed by sonica- 
tion. The supernatant pH was adjusted to 7.4 with 
KOH and the KC104 precipitate removed by cen- 
trifugation. The supernatant was evaporated to 
dryness with rotovapor and the residue suspended 
in 2H&-EDTA (100 mM), reading pH 7.0, for 
NMR measurements. 
2.3 + Nuclear magnetic resonance 
31P NMR spectra were recorded at 40.5 MHz 
from packed cell suspensions of FLC (2-3 x lo9 
cells/ml in 2HzO-saline) or from extracts by means 
of a Varian XL 100 spectrometer byfollowing pro- 
cedures previously described [ 111. Chemical shifts 
were measured in ppm with respect to 85% phos- 
phoric acid (external reference). Signals were iden- 
tified and the concentrations of the relative com- 
pounds measured in the extracts by adding known 
amounts of the respective standard compounds 
and observing both integral variations and the pH 
dependence of their chemical shifts. The quan- 
titative analysis of the extracts was carried out by 
using a Bruker AM 400 WB spectrometer. 
3. RESULTS 
The typical 3tP NMR spectrum obtained be- 
tween + 6 ppm and - 3 ppm from FLC grown 4 
days in vitro is shown in fig. la. The analysis of the 
spectrum of the PCA extract (fig2a) allowed the 
identi~~tion of the resonances II, III and IV of 
the cell suspension as due to inorganic phosphate 
(pi, + 1.81 ppm), GroPEtn (+0.35 ppm) and 
GroPCho ( - 0.20 ppm), respectively. The dif- 
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Fig. 1. “P NMR spectra (4”C, 60° r.f. pulse, acquisition 
time 1 s) of Friend erythroleukemia cells, clone 745A, 
grown for 4 days in vitro in medium containing: (a) no 
inducer (4412 scans); (b) 1.5% DMSO (3891 scans); (c) 
5 mhf HMBA (4257 scans; amplification 3 x that used 
for (a) and (b). 
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Fig. 2. 31P NMR spectra (30°C, 60” r.f. pulse, acquisi- 
tion time 1.5 s) of PCA extracts of the same Friend 
erythroleukemia ceils as in fig. 1: (a) no inducer; (h) 
1.5% DMSO; (c) 5 mM HMBA (amplification 1.33 x 
that used for (a) and (h). 
ference of about 0.7 ppm between the chemical 
shift of GroPCho (or GroPEtn) measured here, us- 
ing an el~trom~et, and that reported in [S] us- 
ing a su~rcond~~tive magnet, is due to the dif- 
ferent alignment of the magnetic field with respect 
to the sample axis in the two spectrometers (dia- 
magnetic su~eptjbil~y effect [ 161). Band I (be- 
tween 3 and 4 ppm) appeared to be essentially com- 
posed of two resonances, identified as AMP and 
P-Cho in the PCA extract. By adjusting the pH of 
the latter to a value at which the chemical shift of 
Pi (S = 1.88 ppm) was very close to that of in- 
tracellular Pi in the intact cells, the signals of AMP 
and P-Cho appeared to be separated by +0.15 
ppm, whereas they tended to overlap when pH was 
decreased by about 0.2 units. The spectra reported 
in fig. I b,c were obtained from FLC treated 4days 
with either DMSO or HMBA, The shift of their 
respective Pi resonances (not ahown) indhated that 
the average intracellular pH decreased by about 
0.1 units in cells treated with DMSO and 0.2 units 
in those treated with HMBA (the pH values 
estimated from the titration curve reported in [17] 
for 5 mM potassium pho~hate in the presence of 
0.1 M KCl, were 7.0, 6.9 and 6.8 respectively, in
untreated cells and in cells differentiated with 
DMSO or HMBA). The slight intracelhrlar cidifi- 
cation was responsible for the almost complete 
overlapping of the AMP and P-Cho signals in the 
HMBA-treated cells (fig. lc). 
The spectra of intact cells showed that the GroP- 
Cho level decreased in both DMSG- and HMBA- 
diff~entiat~ FLC, whereas the P-Cho content ex- 
hibited conspicuous increments. These effects were 
much more evident in HMBA-treated cells. Similar 
results were obtained in another two experiments 
carried out on DMSO-induced cell cultures (clone 
745A and 745-E7), while no variations in the ratio 
between the areas of P-Cho and GroPCho were 
observed in FLC {clone 745) after 2 h of treatment 
with DMSG (not shown). 
The contents of GroPCho and P-Cho deter- 
mined in the PCA extracts of untreated and dif- 
ferentiated cells are reported in table 1. The ratio 
Table 1 
Concentrations of phosphorylcholine and glycerophosphorylcholine in 
PCA extracts of control and differentiated Friend erythroleukemia cells 
Treatment ~n~~rn~~sitive p-Cho] R&o-PChol fGroPCho] 
cells on day 4 (Yo) (crmol/109 +moI/109 -ff_ca6t 
cehs) C&S 
None <1 0.5 
DMSO 59 0.8 
HMBA 76 1.2 
3.4 
1.1 
below detec- 
tion 
6.8 
1.4 
-0 
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between the concentrations of GroPCho and P- 
Cho showed a 5-fold decrease in the extract of 
DMSO-treated with respect to untreated FLC and 
practically vanished in that of HMBAdifferen- 
tiated cells. The concentrations reported in table 1 
represent the intracellular levels of the corre- 
sponding compounds in intact cells, within the 
errors brought about by the extraction procedures. 
The spectra of the PCA extracts actually show that 
the extraction yield of GroPCho is somewhat 
lower than that of P-Cho. In particular, although 
GroPCho gave rise to a signal of very small intensi- 
ty in HM%BA-treated cells, it was not possible to 
evidentiate its resonance above the noise in the 
corresponding PCA extract. 
4. DISCUSSION 
High levels of GroPCho in FLC have already 
been reported in [8]. The fact that the GroPCho 
concentration found in our control cells is about 
half that observed in [8] could be ascribed to 
several possible reasons: (i) although derived from 
the same original clone (745A) these cells have 
been passaged for many years in different culture 
conditions (media and percentages of foetal calf 
serum); (ii) the experimental conditions necessary 
to obtain high percentages of differentiated cells 
were different from those used by authors in [8]. 
These differences in cell growth conditions could 
be very relevant in modulating the levels of GroP- 
Cho as suggested by the modulations of this com- 
pound in other cell systems [11,12]. 
An increase in the ‘H NMR signal (only one) 
arising from both GroPCho and P-Cho was 
already observed [13] in FLC induced to differen- 
tiate by DMSO. However, the method used did not 
allow the discrimination of the individual modula- 
tions undergone by these two compounds: 
ase [18] or lysophospholipase activity, whereas P- 
Cho would occur primarily as an intermediate in 
the major mechanism of PtdCho biosynthesis [19], 
a process known to be controlled mainly by 
cytidyltransferase [20]. The possibility that P-Cho 
might simply be a degradation product cannot be 
excluded a priori. However, a phospholipase C- 
mediated degradation of PtdCho into P-Cho ap- 
pears unlikely as this enzyme has been found 
generally in bacteria, whereas in mammalian cells 
it seems to exhibit prevailing specificity for 
phospholipids different from PtdCho [ 181. On the 
other hand, the existence of an enzyme with novel 
phosphodiesterase activity leading from GroPCho 
to P-Cho was reported in 1975 in rat brain 
homogenates [21]. Although no further studies 
have been carried out, to our knowledge, to in- 
vestigate the presence of this enzyme in other 
systems, the results of these experiments indicate 
the interest of assessing whether such enzyme is 
also possibly present in FLC and in other tumor 
cells. In the case of a lack of such an enzyme in our 
system, an increase of the P-Cho level could in 
principle be ascribed to: (i) an increase in the pool 
of intracellular choline; (ii) an enhancement of 
phosphokinase activity, or (iii) an inhibition of the 
cytidyltransferase activity, resulting in the ac- 
cumulation of its substrate. The observation 
(derived from fig. 2 of [13]) that choline content is 
maintained constant during DMSO-induced dif- 
ferentiation, seems to exclude the first hypothesis. 
On the other hand, a decrease in the GroPCho 
content might derive from (i) a reduction in the 
PtdCho level, or (ii) a modulation of combined 
phospholipase A activity [18]. The latter mechan- 
ism seems to be favored in view of the fact that 
PtdCho is reported to be either increased or main- 
tained practically constant in differentiated FLC 
La. 
To our knowledge, our results give the first ex- The fact that levels of GroPCho and P-Cho 
ample of modulations of both GroPCho and P- undergo concomitant modulations in differen- 
Cho in a cell system undergoing erythroid differen- tiated FLC suggests the hypothesis that erythroid 
tiation. A decrease in the GroPCho level occurring differentiation might result in some modifications 
in differentiated FLC is in fact associated to an in- of the regulatory mechanisms controlling biosyn- 
crease of P-Cho. Such an association is rather in- thesis and catabolism of phospholipids. 
triguing. According to the classical biochemical Further studies are necessary in order to elucid- 
pathways of biosynthesis and degradation of ate at which stage of in vitro-induced erythroid dif- 
phosphatidylcholine (PtdCho), GroPCho is gener- ferentiation these modulations occur. However, 
ally assumed to be primarily the result of degrada- although the biochemical events controlling these 
tion of PtdCho via the expression of phospholip- changes, as well as their functional correlations 
91 
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with the differentiation process, are still unknown, 
these metabolic modulations seem to represent ad- 
ditional markers appearing in in vitro differen- 
tiated FLC. 
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